GW Pharmaceuticals Plc
(NASDAQ : GWPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
CTLTCatalent, Inc. 0.01%85.202.1%$238.74m
SAVACassava Sciences, Inc. -0.37%11.370.0%$210.59m
JAZZJazz Pharmaceuticals Plc 2.34%143.012.4%$168.45m
HZNPHorizon Therapeutics Plc -0.97%77.405.8%$167.80m
MRNSMarinus Pharmaceuticals, Inc. 6.71%12.407.8%$135.91m
CORTCorcept Therapeutics, Inc. -1.08%17.365.5%$122.55m
VRXValeant Pharmaceuticals International, Inc. 4.17%15.5014.1%$91.20m
BHCBausch Health Cos., Inc. 4.20%15.510.0%$63.08m
MYOKMyoKardia, Inc. 0.82%135.231.8%$62.73m
AMRNAmarin Corp. Plc 2.48%4.141.5%$59.93m
ARGXargenx SE 0.81%262.310.0%$56.10m
SAGESAGE Therapeutics, Inc. 1.09%60.328.6%$44.61m
GWPHGW Pharmaceuticals Plc -0.51%97.336.2%$39.19m
AXSMAxsome Therapeutics, Inc. -1.91%70.901.9%$38.21m
PRGOPerrigo Co. Plc 0.33%45.826.8%$36.90m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.